Date,Title,Source
2025-08-29T06:02:49Z,Biotech Stocks Worth Watching – August 27th,ETF Daily News
2025-08-26T09:00:00Z,Scenic Enters License and Research Agreement with Alnylam,GlobeNewswire
"Sun, 31 Aug 2025 06:01:21 GMT",Smart tools for monitoring ALNY’s price action - CEO Change & Free High Return Stock Watch Alerts - Newser,Newser
"Sat, 30 Aug 2025 15:19:38 GMT",Alnylam posts mid-stage trial setback for heart drug (ALNY) - Seeking Alpha,Seeking Alpha
"Sat, 30 Aug 2025 14:30:00 GMT",Blood Pressure Drug Cuts SBP by 9.2mmHg: Alnylam's Zilebesiran Shows Promise in High-Risk Patient Study - Stock Titan,Stock Titan
"Sat, 30 Aug 2025 19:08:20 GMT",Alnylam Pharmaceuticals: A High-Conviction Buy Amid Record Revenue Growth and Strategic Pipeline Momentum - AInvest,AInvest
"Sat, 30 Aug 2025 18:29:26 GMT",Long term hold vs stop loss in ALNY - July 2025 Volume & AI Optimized Trade Strategies - Newser,Newser
"Sun, 31 Aug 2025 00:03:15 GMT",ALNY’s volatility index tracking explained - Earnings Summary Report & Weekly Top Gainers Alerts - Newser,Newser
"Sat, 30 Aug 2025 15:04:16 GMT",Alnylam's Zilebesiran: A Game-Changer in Hypertension and Cardiovascular Outcomes? - AInvest,AInvest
"Wed, 27 Aug 2025 12:00:00 GMT",Leading RNAi Therapeutics Company Alnylam Set for Key September Healthcare Conference Circuit - Stock Titan,Stock Titan
"Sat, 30 Aug 2025 22:52:49 GMT",ALNY’s volatility index tracking explained - Weekly Profit Analysis & Free Daily Entry Point Trade Alerts - Newser,Newser
"Fri, 29 Aug 2025 23:40:21 GMT",Alnylam Pharmaceuticals Shares Drop 1.29% With 0.37 Billion Volume Ranking 263rd as Clinical Advances Continue - AInvest,AInvest
"Sun, 31 Aug 2025 03:28:38 GMT",Smart tools for monitoring ALNY’s price action - July 2025 Update & Fast Gain Stock Trading Tips - Newser,Newser
"Sat, 30 Aug 2025 20:46:58 GMT",Long term hold vs stop loss in ALNY - Risk Management & Expert Approved Momentum Trade Ideas - Newser,Newser
"Sun, 31 Aug 2025 02:03:21 GMT",Will ALNY stock recover after recent drop - July 2025 Levels & Verified Swing Trading Watchlist - Newser,Newser
"Sat, 30 Aug 2025 22:22:16 GMT",Multi factor analysis applied to ALNY - Watch List & High Accuracy Swing Entry Alerts - Newser,Newser
"Thu, 28 Aug 2025 12:59:09 GMT",Can swing trading help recover from ALNY losses - July 2025 Gainers & Consistent Income Trade Ideas - Newser,Newser
"Wed, 27 Aug 2025 23:03:07 GMT",Combining price and volume data for ALNY - July 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser,Newser
"Thu, 28 Aug 2025 04:18:12 GMT",Forecasting ALNY price range with options data - July 2025 Retail & Advanced Technical Signal Analysis - Newser,Newser
"Fri, 29 Aug 2025 18:46:43 GMT",ALNY’s volatility index tracking explained - Profit Target & Step-by-Step Trade Execution Guides - Newser,Newser
"Thu, 28 Aug 2025 22:49:00 GMT",Alnylam's First-Half Sales Surge 89% to $801.9M While Stock Slumps 0.41% on $290M Volume Slump to 341st Rank - AInvest,AInvest
"Fri, 29 Aug 2025 12:04:11 GMT",Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum? - MSN,MSN
"Sun, 31 Aug 2025 02:06:25 GMT",RSI + MACD Show Convergence for ALNY getLinesFromResByArray error: size == 0 - newsyoung.net,newsyoung.net
"Fri, 29 Aug 2025 16:42:02 GMT",Smart tools for monitoring ALNY’s price action - July 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser,Newser
"Thu, 28 Aug 2025 19:13:36 GMT",ALNY’s volatility index tracking explained - Market Performance Report & Long-Term Capital Growth Ideas - Newser,Newser
"Sat, 30 Aug 2025 14:30:00 GMT",Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension - Yahoo Finance,Yahoo Finance
"Sat, 30 Aug 2025 18:56:21 GMT",Alnylam Pharmaceuticals Special Call Transcript - AInvest,AInvest
"Wed, 27 Aug 2025 12:00:00 GMT",Alnylam to Webcast Presentations at Upcoming September Investor Conferences - Business Wire,Business Wire
"Thu, 28 Aug 2025 03:58:22 GMT",Alnylam's NeuroFeeL Study: A Potential Breakthrough in hATTR Amyloidosis Treatment - AInvest,AInvest
"Thu, 28 Aug 2025 03:58:23 GMT",Alnylam Pharmaceuticals' ELEVATE Study: Unlocking Insights into AHP Management - AInvest,AInvest
"Tue, 26 Aug 2025 09:00:00 GMT",Scenic Enters License and Research Agreement with Alnylam - uk.finance.yahoo.com,uk.finance.yahoo.com
"Thu, 28 Aug 2025 04:06:22 GMT",Alnylam's Breakthrough Liver Cancer Study: A Promising Phase 1 Update - AInvest,AInvest
"Thu, 28 Aug 2025 03:56:42 GMT",Alnylam's Patisiran-LNP Pregnancy Surveillance Study: Key Insights for Investors - AInvest,AInvest
"Tue, 26 Aug 2025 12:13:39 GMT",Regeneron posts late-stage trial win for myasthenia gravis drug developed with Alnylam - Seeking Alpha,Seeking Alpha
"Sun, 31 Aug 2025 05:34:51 GMT",Alnylam jumps on full year revenue guidance raise - MSN,MSN
"Sun, 31 Aug 2025 01:43:08 GMT",Regression analysis insights on ALNY performance - Jobs Report & Precise Swing Trade Alerts - Newser,Newser
"Sat, 30 Aug 2025 17:54:57 GMT",Regression analysis insights on ALNY performance - Portfolio Risk Summary & Reliable Entry Point Trade Alerts - Newser,Newser
"Sat, 30 Aug 2025 02:56:43 GMT",How to build a custom watchlist for ALNY - Profit Target & Verified Stock Trade Ideas - Newser,Newser
2025-08-28T16:10:00,Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?,Yahoo
2025-08-28T15:53:00,"Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals",Yahoo
2025-08-27T14:00:00,Alnylam to Webcast Presentations at Upcoming September Investor Conferences,Yahoo
2025-08-26T16:00:07,"Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)",Yahoo
2025-08-26T11:00:00,Scenic Enters License and Research Agreement with Alnylam,Yahoo
